Table 2.

Summary of pretreatment antipsychotic drug use during cross-titration period

	Asenapine (n = 485)	Olanzapine (n = 464)
Antipsychotics, n (%)
Total	467 (96.3)	452 (97.4)
1	329 (67.8)	335 (72.2)
2	107 (22.1)	93 (20.0)
3 or more	31 (6.4)	24 (5.2)
Antipsychotic class, n (%)
FGA	151 (31.1)	138 (29.7)
SGA	386 (79.6)	363 (78.2)
Depot	60 (12.4)	53 (11.4)
Antipsychotic, n (%)
SGA
Olanzapine	132 (27.2)	109 (23.5)
Risperidone	163 (33.6)	151 (32.5)
Quetiapine	63 (13.0)	57 (12.3)
Ziprasidone	16 (3.3)	22 (4.7)
Aripiprazole	28 (5.8)	41 (8.8)
Amisulpride	17 (3.5)	14 (3.0)
Clozapine	14 (2.9)	8 (1.7)
Clotiapine	4 (0.8)	0 (0.0)
Paliperidone	2 (0.4)	3 (0.6)
Ziprasidone mesilate	2 (0.4)	2 (0.4)
Zotepine	0 (0.0)	2 (0.4)
Melperone hydrochloride	0 (0.0)	1 (0.2)
Sertindole	0 (0.0)	1 (0.2)
FGA
Haloperidol	53 (10.9)	47 (10.1)
Chlorpromazine	12 (2.5)	23 (5.0)
Levomepromazine	14 (2.9)	9 (1.9)
Fluphenazine	11 (2.3)	9 (1.9)
Trifluoperazine	9 (1.9)	11 (2.4)
Promethazine	10 (2.1)	7 (1.5)
Sulpiride	8 (1.6)	5 (1.1)
Thioridazine	5 (1.0)	3 (0.6)
Chlorprothixene	4 (0.8)	11 (2.4)
Loxapine	4 (0.8)	2 (0.4)
Cyamemazine	4 (0.8)	2 (0.4)
Tiapride	2 (0.4)	0 (0.0)
Pipotiazine	1 (0.2)	1 (0.2)
Benperidol	1 (0.2)	0 (0.0)
Pimozide	1 (0.2)	0 (0.0)
Thioproperazine	1 (0.2)	0 (0.0)
Zuclopenthixol	1 (0.2)	1 (0.2)
Depot
Fluphenazine decanoate	11 (2.3)	13 (2.8)
Flupentixol	19 (3.9)	21 (4.5)
Zuclopenthixol	15 (3.1)	6 (1.3)
Flupentixol decanoate	0 (0.0)	2 (0.4)
Haloperidol decanoate	8 (1.6)	8 (1.7)
Perphenazine	8 (1.6)	3 (0.6)
Perphenazine enantate	0 (0.0)	2 (0.4)
Zuclopenthixol decanoate	1 (0.2)	1 (0.2)
Perphenazine decanoate	1 (0.2)	0 (0.0)

Abbreviations: FGA, first-generation antipsychotic; SGA, second-generation antipsychotic.